GC
BDSI

Guggenheim Capital’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Guggenheim Capital’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-16,200
Closed -$195K – 3303
2014
Q2 		$195K Sell
16,200
-2,604
-14% -$24.7K ﹤0.01% 2909
2014
Q1 		$159K Buy
18,804
+3,061
+19% +$24.7K ﹤0.01% 2942
2013
Q4 		$93K Buy
15,743
+704
+5% +$3.63K ﹤0.01% 2991
2013
Q3 		$82K Buy
15,039
+843
+6% +$4.05K ﹤0.01% 2882
2013
Q2 		$58K Buy
+14,196
New +$66.6K ﹤0.01% 2894

Other funds holding BDSI

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.51B AUM 37.25% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Guggenheim Capital's BDSI Position: Q3 2014 in Review

Guggenheim Capital sold out of BioDelivery Sciences International, Inc. (BDSI) in Q3 2014, closing a stake of 16,200 shares — an estimated $195K sold.

Guggenheim Capital first reported a position in BDSI in Q2 2013 and held it in 5 quarters. The position peaked at $195K in Q2 2014. 116 funds tracked by Wall St. Rank hold BDSI as of Q3 2014.

  • Guggenheim Capital reported no remaining BioDelivery Sciences International, Inc. position as of Q3 2014 after selling out during the quarter.
  • Guggenheim Capital sold 16,200 BioDelivery Sciences International, Inc. shares in Q3 2014, an estimated $195K.
  • Guggenheim Capital first reported a position in BioDelivery Sciences International, Inc. in Q2 2013 and held it in 5 quarters.
  • Guggenheim Capital's BioDelivery Sciences International, Inc. position peaked at $195K in Q2 2014.
  • 116 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q3 2014.

Based on Guggenheim Capital's 13F filing for Q3 2014, filed 14 Nov 2014.